Boston Scientific Corporation logo

Boston Scientific Corporation (BSX)

Market Closed
4 Jun, 20:00
NYSE NYSE
$
48. 85
+1.16
+2.4324%
$
70.87B Market Cap
74.55 P/E Ratio
- Div Yield
22.68M Volume
2.01 Eps
$ 47.69
Previous Close
Add Transaction
Day Range
48.27 49.47
Year Range
47.17 109.5
Want to track BSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Boston Scientific (BSX) is a Strong Growth Stock

Here's Why Boston Scientific (BSX) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain?

BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain?

Boston Scientific received FDA approval on the expanded indication for INGEVITY+ Pacing Leads. Data demonstrated this lead to be safe and effective for LBBA pacing.

Zacks | 1 year ago
Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note

Boston Scientific (BSX) Stock Drops Despite Market Gains: Important Facts to Note

Boston Scientific (BSX) closed the most recent trading day at $82.52, moving -1.19% from the previous trading session.

Zacks | 1 year ago
Boston Scientific: Why This MedTech Giant Isn't Slowing Down

Boston Scientific: Why This MedTech Giant Isn't Slowing Down

Boston Scientific Co NYSE: BSX is a global medical device manufacturer that's seeing a strong influx of investors as shares grind to new all-time highs. The company has a vast portfolio of devices to diagnose and treat medical conditions.

Marketbeat | 1 year ago
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts

Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts

In the closing of the recent trading day, Boston Scientific (BSX) stood at $82.94, denoting a -0.14% change from the preceding trading day.

Zacks | 1 year ago
Pick Boston Scientific Stock After 130% Gains?

Pick Boston Scientific Stock After 130% Gains?

Boston Scientific (NYSE: BSX) has more than doubled in value since early January 2021 – jumping from levels of $36 then to around $82 now – vs. an increase of about 45% for the S&P 500 over this period.

Forbes | 1 year ago
Boston Scientific Corporation (BSX) Wells Fargo 2024 Healthcare Conference (Transcript)

Boston Scientific Corporation (BSX) Wells Fargo 2024 Healthcare Conference (Transcript)

Boston Scientific Corporation (NYSE:BSX ) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:00 AM ET Company Participants Brad Sutton - Chief Medical Officer, AF Solutions Jon Monson - SVP, IR Michael F. Mahoney - Chairman and CEO Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities Lawrence Biegelsen Okay.

Seekingalpha | 1 year ago
Boston Scientific Shares Rising Higher

Boston Scientific Shares Rising Higher

Medical device maker Boston Scientific Corporation (BSX) shares rising on product, financial performance.

Fxempire | 1 year ago
Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider

In the most recent trading session, Boston Scientific (BSX) closed at $81.79, indicating a +1.39% shift from the previous trading day.

Zacks | 1 year ago
Boston Scientific's ACURATE Prime Aortic Valve System Wins CE Mark

Boston Scientific's ACURATE Prime Aortic Valve System Wins CE Mark

BSX achieves CE Mark approval for the ACURATE Prime Aortic Valve System, its latest TAVR technology.

Zacks | 1 year ago
Why Is Boston Scientific (BSX) Up 7.2% Since Last Earnings Report?

Why Is Boston Scientific (BSX) Up 7.2% Since Last Earnings Report?

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why

Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why

Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
Loading...
Load More